The invention provides methods for prognosis, diagnosis, staging and disease progression in human cancer patients related to expression levels of a plurality of genes that are differentially expressed in anti-angiogenic agent-sensitive and anti-angiogenic agent-resistant vascular endothelial cells as compared to baseline vascular endothelial cells.

 
Web www.patentalert.com

< Method for supporting secondary address delivery on remote access servers

< Fluid guidance piece with internal temperature equalization

> Method for immobilizing conjugates in diagnostic tests

> System and method for insuring dynamic host configuration protocol operation by a host connected to a data network
~ 00237